Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Supplement—December 2022
SUPPLEMENT ISSUE
Clinical

Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021

Kwame Amponsa-Achiano, Joseph Asamoah FrimpongComments to Author , Danielle Barradas, Delia Akosua Bandoh, and Ernest Kenu
Author affiliations: Expanded Program on Immunization, Ghana Health Service, Accra, Ghana (K. Amponsa-Achiano); Ghana Field Epidemiology and Laboratory Training Programme, University of Ghana, Accra (J.A. Frimpong, D.A. Bandoh, E. Kenu); US Centers for Disease Control and Prevention, Accra (D. Barradas)

Main Article

Figure

Distribution of phase 1 COVID-19 vaccination campaign deployment by district, Ghana, March 1–August 23, 2021. Based on population and geographic segmentation, phase 1A targeted the most at-risk groups in 43 hotspot districts; phase 1B targeted all healthcare workers; phase 1C targeted all persons vaccinated in phase 1A during within March 1–9, 2021 (12 weeks after first dose); phase 1D targeted 2021 census enumerators (first dose) and second-dose vaccinations in selected districts; and phase 1E targeted the general population in same districts. Phase 1E vaccination was with the Janssen/Johnson & Johnson vaccine (https://www.jnj.com).

Figure. Distribution of phase 1 COVID-19 vaccination campaign deployment by district, Ghana, March 1–August 23, 2021. Based on population and geographic segmentation, phase 1A targeted the most at-risk groups in 43 hotspot districts; phase 1B targeted all healthcare workers; phase 1C targeted all persons vaccinated in phase 1A during within March 1–9, 2021 (12 weeks after first dose); phase 1D targeted 2021 census enumerators (first dose) and second-dose vaccinations in selected districts; and phase 1E targeted the general population in same districts. Phase 1E vaccination was with the Janssen/Johnson & Johnson vaccine (https://www.jnj.com).

Main Article

Page created: October 05, 2022
Page updated: December 11, 2022
Page reviewed: December 11, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external